Positive impactIPO
IPO GMP Today: Dhoot Transmission vs Molbio Diagnostics—Which IPO Offers Better Listing Gains?
NDTV Profit 1 hr ago·12 Aug 2026, 6:54 am
Dhoot Transmission is currently showing a higher grey market premium (GMP) than Molbio Diagnostics, suggesting it could list at a higher percentage gain relative to its issue price. A GMP is an unofficial indicator of investor sentiment and trading expectations before the stock actually starts trading on the exchanges. This premium is calculated based on the current market value versus the price set by the company during its initial public offering.
For investors, this information helps gauge the potential listing day performance of these stocks. While a higher GMP like Dhoot Transmission's 30% estimate implies strong demand, it is not a guarantee of the final listing price. The actual listing gain will depend on market conditions, the overall sentiment towards IPOs, and the final allotment status on the listing day.
Investors should watch for the final price band announcement and the subscription numbers. A strong subscription, especially from qualified institutional buyers, often supports a higher listing premium. However, it is crucial to remember that grey market premiums are speculative and subject to market volatility.
Key takeaways
- Category: IPO.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
